3 ms·
This sounds like the best way to do it. The company would still need a blinded control group to be able to demonstrate the effectiveness of any treatment. How
by londons_explore 3y ago
This sounds like the best way to do it.
The company would still need a blinded control group to be able to demonstrate the effectiveness of any treatment.
However patients should be allowed to enroll for free into multiple treatment trials at the same time. For a given number of people and treatments, enrolling in multiple trials simultaneously gives more science output, and more chance of success for the participants, if you assume that ineffective treatments rarely are very harmful.
- hutzlibu 3y ago"However patients should be allowed to enroll for free into multiple treatment trials at the same time." But this would likely mess up any data, you can get. How can you tie the cure or the bad sideeffects to any drug then? Apart from that, sure, I think patients should have the right to try anything.
- londons_explore 3y agoBad side effects caused by participating in other trials would happen with equal frequencies in the control group.
- mitthrowaway2 3y agoYou just end up with a matrix of treatments. Whatever results you observe from someone undergoing treatments X & Y goes in the "X&Y" box, not the X box and the Y box.
- Detrytus 3y agoBut you would need much more participants in all trials, to make up for all those new combos that you now have to consider. Also: I can imagine that most of the patients would be eager to engage in all possible treatments. You might not even have a control group that did not participate in the study of the faulty drug X
- mitthrowaway2 3y agoThen all you get is data about the effectiveness of XY. Would it be any better if only X was tested, but it turned out that that one drug 'X' contained two separate active ingredients, each of which the pharmaceutical company thought would probably be an effective treatment?